ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,307Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 1001

$2.55M Total Retail Price of All Prescriptions

Rank: 4 out of 1001

860 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 860 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 860 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 19,596 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $112 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
ZOLPIDEM TARTRATE 1,066 701 1 12
MELOXICAM 1,025 695 2 35
OMEPRAZOLE 1,010 679 3 3
NEXIUM 1,006 614 4 16
AMLODIPINE BESYLATE 691 522 5 2
SIMVASTATIN 689 559 6 1
METFORMIN HCL 589 399 7 11
HYDROCHLOROTHIAZIDE 560 364 8 19
CELEBREX 559 376 9 78
DIOVAN HCT 506 349 10 61
ADVAIR DISKUS 455 216 11 46
LISINOPRIL 439 277 12 10
CRESTOR 425 287 13 14
MECLIZINE HCL 402 300 14 153
CLOTRIMAZOLE-BETAMETHASONE 375 233 15 125
IBUPROFEN 362 193 16 143
ATENOLOL 345 289 17 18
VOLTAREN 342 239 18 115
PATANOL 336 186 19 166
LOVAZA 313 224 20 39
SINGULAIR 311 195 21 67
ALENDRONATE SODIUM 301 229 22 32
DICLOFENAC SODIUM 291 163 23 123
FUROSEMIDE 272 206 24 7
GABAPENTIN 270 189 25 17
ENDOCET 268 145 S2 26 213
METOPROLOL TARTRATE 259 174 27 9
AMMONIUM LACTATE 253 180 28 58
TRAMADOL HCL 247 186 29 51
AMITIZA 246 143 30 251
PLAVIX 245 216 31 29
FLUTICASONE PROPIONATE 242 171 32 27
SOLARAZE 239 156 33 141
FLECTOR 234 134 10 34 310
CLOPIDOGREL 229 180 35 28
VENTOLIN HFA 225 85 36 127
METOPROLOL SUCCINATE 223 166 37 6
OXYCODONE HCL 222 128 S2 38 50
LEVOTHYROXINE SODIUM 213 164 39 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 212 127 40 120
LOSARTAN-HYDROCHLOROTHIAZIDE 211 149 41 65
JANUVIA 196 108 42 49
ACTOS 190 146 43 185
NAPROXEN 185 107 44 139
TAMSULOSIN HCL 183 147 45 4
DIOVAN 182 113 46 26
MICARDIS HCT 181 136 47 317
LOSARTAN POTASSIUM 178 145 48 15
LANSOPRAZOLE 174 100 49 297
ATORVASTATIN CALCIUM 173 105 50 8
DONEPEZIL HCL 166 145 51 25
MEGESTROL ACETATE 163 149 R 52 293
CARVEDILOL 141 105 53 22
METOCLOPRAMIDE HCL 140 94 54 189
CICLOPIROX 138 83 55 109
ZETIA 137 98 56 96
PROAIR HFA 135 68 57 74
AMLODIPINE BESYLATE-BENAZEPRIL 131 99 58 164
NASONEX 131 96 58 129
AVODART 128 98 60 33
LYRICA 122 89 61 117
HYDROCORTISONE 121 77 62 273
CYMBALTA 121 38 62 73
ZOVIRAX 120 78 10 64 318
MONTELUKAST SODIUM 116 63 65 158
MAXALT 115 61 10 66 456
GLIMEPIRIDE 115 87 66 72
ESCITALOPRAM OXALATE 114 63 68 110
OXISTAT 112 66 10 69 462
EXFORGE 111 84 70 217
SYMBICORT 106 67 71 199
CYCLOBENZAPRINE HCL 103 36 R 72 169
PREDNISONE 103 41 72 24
GLIPIZIDE 99 63 74 145
METHOCARBAMOL 93 29 R 75 392
LANTUS 89 75 76 137
FLUOCINONIDE 89 65 76 85
ENALAPRIL MALEATE 89 52 76 42
JANUMET 88 77 79 194
PROCTOZONE-HC 88 45 79 210
CIPROFLOXACIN HCL 86 64 81 30
GLYBURIDE-METFORMIN HCL 85 82 R 82 186
AMOXICILLIN 85 61 82 232
EXELON 83 83 84 87
CROMOLYN SODIUM 81 60 85 405
TRAMADOL HCL-ACETAMINOPHEN 79 53 86 171
AZOR 76 58 87 260
LIDODERM 75 52 88 108
NIFEDIPINE ER 74 42 89 93
GLYBURIDE 74 53 R 89 192
NAMENDA 74 74 89 31
BETAMETHASONE DIPROPIONATE 73 43 92 235
MICARDIS 73 52 92 200
SPIRIVA 70 56 94 56
VALACYCLOVIR 70 27 94 303
SERTRALINE HCL 69 41 96 36
CLOBETASOL PROPIONATE 69 43 96 48
HYDROCODONE-ACETAMINOPHEN 68 33 S3 98 21
QUETIAPINE FUMARATE 67 44 99 76
VALSARTAN-HYDROCHLOROTHIAZIDE 65 37 100 448
PRISTIQ ER 64 52 101 337
TRIAMCINOLONE ACETONIDE 64 40 101 80
LACLOTION 63 51 103 261
BUSPIRONE HCL 62 26 104 162
EVISTA 61 27 105 88
LABETALOL HCL 58 52 106 181
BYSTOLIC 58 39 106 92
PAROXETINE HCL 58 43 106 98
KRISTALOSE 58 49 106 459
LIPITOR 57 45 110 71
DEXILANT 57 24 110 116
ISOSORBIDE MONONITRATE ER 57 54 110 66
HYDROXYZINE HCL 57 23 R 110 165
PANTOPRAZOLE SODIUM 55 45 114 63
AZITHROMYCIN 54 32 115 54
RANITIDINE HCL 54 50 115 52
METAXALONE 53 25 R 117 447
IBANDRONATE SODIUM 53 41 117 423
NEOMYCIN-POLYMYXIN-HYDROCORT 52 26 119 417
OXYCODONE HCL-ACETAMINOPHEN 52 20 S2 119 140
CITALOPRAM HBR 52 22 119 47
CLONIDINE HCL 52 34 119 124
LEXAPRO 51 22 123 250
NYSTATIN 50 30 124 331
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.